edoxaban   Click here for help

GtoPdb Ligand ID: 7575

Synonyms: DU-176 | DU-176b | edoxaban tosylate | Lixiana® | Savaysa®
Approved drug
edoxaban is an approved drug (EMA & FDA (2015))
Compound class: Synthetic organic
Comment: Edoxaban is an oral, once-daily factor Xa inhibitor anticoagulant.
Marketed formulations contain edoxaban tosylate (PubChem CID 44610678).
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: edoxaban

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 11
Hydrogen bond donors 3
Rotatable bonds 10
Topological polar surface area 164.87
Molecular weight 547.18
XLogP -0.22
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES CN1CCc2c(C1)sc(n2)C(=O)NC1CC(CCC1NC(=O)C(=O)Nc1ccc(cn1)Cl)C(=O)N(C)C
Isomeric SMILES CN1CCc2c(C1)sc(n2)C(=O)N[C@@H]1C[C@H](CC[C@@H]1NC(=O)C(=O)Nc1ccc(cn1)Cl)C(=O)N(C)C
InChI InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15-,17+/m0/s1
No information available.
Summary of Clinical Use Click here for help
This drug was initially approved in Japan for the treatment of venous thromboembolism (VTE). Subsequently, in 2015, the US FDA and EMA approved edoxaban to reduce the risk of stroke and systemic embolism in patients with atrial fibrillation that is not caused by a heart valve problem and to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients who have already received anti-clotting therapy for five to ten days.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Edoxaban acts as a direct factor Xa inhibitor. This family of drugs inhibits coagulation without using antithrombin as a mediator.
External links Click here for help